MOBIC vs XIFYRM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Attribute	MOBIC	XIFYRM
Rating	72/100	70/100
Pharmacy pays	~$0.56 /30	~$0.56 /30
Type	RX	RX
Active ingredient	MELOXICAM	MELOXICAM
Manufacturer	Boehringer Ingelheim	Azurity
Dosage forms	Tablet	Injectable
Drug class	Nonsteroidal Anti-Inflammatory Drug	Nonsteroidal Anti-Inflammatory Drug
Boxed warning	None	Boxed warning
Half-life	about 15 to 20 hours	about 15 to 20 hours
Treats	Rheumatoid Arthritis, Osteoarthritis	Rheumatoid Arthritis, Osteoarthritis

mobic xifyrm

Rating

72/100

70/100

Pharmacy pays

~$0.56 /30

Type

Active ingredient

MELOXICAM

Manufacturer

Boehringer Ingelheim

Azurity

Dosage forms

Tablet

Injectable

Drug class

Nonsteroidal Anti-Inflammatory Drug

Boxed warning

None

Boxed warning

Half-life

about 15 to 20 hours

Treats

Rheumatoid Arthritis, Osteoarthritis

Frequently asked questions

Which is better-rated, Mobic or Xifyrm?

By our independent rating, Mobic scores higher — 3.6 vs 3.5 out of 5 for Xifyrm. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Mobic or Xifyrm?

Pharmacies pay about the same to acquire either one — roughly $0.56 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Mobic and Xifyrm?

Both Mobic and Xifyrm share the active ingredient Meloxicam.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.